101 related articles for article (PubMed ID: 10966074)
1. Luminacins: a family of capillary tube formation inhibitors from Streptomyces sp. II. Biological activities.
Wakabayashi T; Kageyama-Kawase R; Naruse N; Funahashi Y; Yoshimatsu K
J Antibiot (Tokyo); 2000 Jun; 53(6):591-6. PubMed ID: 10966074
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis of luminacin D.
Shotwell JB; Krygowski ES; Hines J; Koh B; Huntsman EW; Choi HW; Schneekloth JS; Wood JL; Crews CM
Org Lett; 2002 Sep; 4(18):3087-9. PubMed ID: 12201723
[TBL] [Abstract][Full Text] [Related]
3. Luminacins: a family of capillary tube formation inhibitors from Streptomyces sp. I. Taxomony, fermentation, isolation, physico-chemical properties and structure elucidation.
Naruse N; Kageyama-Kawase R; Funahashi Y; Wakabayashi T
J Antibiot (Tokyo); 2000 Jun; 53(6):579-90. PubMed ID: 10966073
[TBL] [Abstract][Full Text] [Related]
4. Characterization of rat aortic fragment within collagen gel as an angiogenesis model; capillary morphology may reflect the action mechanisms of angiogenesis inhibitors.
Hata-Sugi N; Kawase-Kageyama R; Wakabayashi T
Biol Pharm Bull; 2002 Apr; 25(4):446-51. PubMed ID: 11995922
[TBL] [Abstract][Full Text] [Related]
5. Borrelidin is an angiogenesis inhibitor; disruption of angiogenic capillary vessels in a rat aorta matrix culture model.
Wakabayashi T; Kageyama R; Naruse N; Tsukahara N; Funahashi Y; Kitoh K; Watanabe Y
J Antibiot (Tokyo); 1997 Aug; 50(8):671-6. PubMed ID: 9315080
[TBL] [Abstract][Full Text] [Related]
6. Neridronate inhibits angiogenesis in vitro and in vivo.
Ribatti D; Nico B; Mangieri D; Maruotti N; Longo V; Vacca A; Cantatore FP
Clin Rheumatol; 2007 Jul; 26(7):1094-8. PubMed ID: 17106617
[TBL] [Abstract][Full Text] [Related]
7. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.
Deroanne CF; Bonjean K; Servotte S; Devy L; Colige A; Clausse N; Blacher S; Verdin E; Foidart JM; Nusgens BV; Castronovo V
Oncogene; 2002 Jan; 21(3):427-36. PubMed ID: 11821955
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue.
Tremblay PL; Berthod F; Germain L; Auger FA
J Pharmacol Exp Ther; 2005 Nov; 315(2):510-6. PubMed ID: 16055674
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
11. Outer membrane vesicles from Porphyromonas gingivalis affect the growth and function of cultured human gingival fibroblasts and umbilical vein endothelial cells.
Bartruff JB; Yukna RA; Layman DL
J Periodontol; 2005 Jun; 76(6):972-9. PubMed ID: 15948693
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic effect of Biophytum sensitivum is exerted through its cytokine modulation activity and inhibitory activity against VEGF mRNA expression, endothelial cell migration and capillary tube formation.
Guruvayoorappan C; Kuttan G
J Exp Ther Oncol; 2007; 6(3):241-50. PubMed ID: 17552364
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of symmetrical bis-alkynyl or alkyl pyridine and thiophene derivatives and their antiangiogenic activities.
Ahn CM; Shin WS; Bum Woo H; Lee S; Lee HW
Bioorg Med Chem Lett; 2004 Aug; 14(15):3893-6. PubMed ID: 15225692
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of Adonis amurensis components on tube-like formation of human umbilical venous cells.
You YJ; Kim Y; Nam NH; Ahn BZ
Phytother Res; 2003 May; 17(5):568-70. PubMed ID: 12749003
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells.
Juan SH; Lee JL; Ho PY; Lee YH; Lee WS
Eur J Pharmacol; 2006 Jan; 530(1-2):1-8. PubMed ID: 16359657
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenesis effects of borrelidin are mediated through distinct pathways: threonyl-tRNA synthetase and caspases are independently involved in suppression of proliferation and induction of apoptosis in endothelial cells.
Kawamura T; Liu D; Towle MJ; Kageyama R; Tsukahara N; Wakabayashi T; Littlefield BA
J Antibiot (Tokyo); 2003 Aug; 56(8):709-15. PubMed ID: 14563161
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Vietnamese medicinal plants on tube-like formation of human umbilical venous cells.
Nam NH; Kim HM; Bae KH; Ahn BZ
Phytother Res; 2003 Feb; 17(2):107-11. PubMed ID: 12601670
[TBL] [Abstract][Full Text] [Related]
18. Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells.
Komorowski J; Jerczyńska H; Siejka A; Barańska P; Ławnicka H; Pawłowska Z; Stepień H
Life Sci; 2006 Apr; 78(22):2558-63. PubMed ID: 16310808
[TBL] [Abstract][Full Text] [Related]
19. The angiosuppressive effects of 20(R)- ginsenoside Rg3.
Yue PY; Wong DY; Wu PK; Leung PY; Mak NK; Yeung HW; Liu L; Cai Z; Jiang ZH; Fan TP; Wong RN
Biochem Pharmacol; 2006 Aug; 72(4):437-45. PubMed ID: 16793023
[TBL] [Abstract][Full Text] [Related]
20. Tetraarsenic oxide, a novel orally administrable angiogenesis inhibitor.
Park MJ; Park IC; Bae IJ; Seo KM; Lee SH; Hong SI; Eun CK; Zhang W; Rhee CH
Int J Oncol; 2003 Jun; 22(6):1271-6. PubMed ID: 12738993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
